Msc Jane Loh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Msc Jane Loh has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Angela Kaida
Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
1 shared publicationBsn Pauline Voon
British Columbia Centre on Substance Use, Vancouver, Canada
1 shared publication- Cameron Grant
British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada
1 shared publication Mbbs Jane Buxton
School of Population and Public Health, University of British Columbia, British Columbia Centre for Disease Control, Vancouver, Canada
1 shared publication- Michael John Milloy
British Columbia Centre on Substance Use
1 shared publication
Latest Publications
- 19 April 2023
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 19 (3) , 225-237
Estimating the prevalence and correlates of pain among people living with HIV who use unregulated drugs in a Canadian setting
Although prevalent among people living with human immunodeficiency virus (HIV) (PLWH) and people who use unregulated drugs (PWUD), pain and its possible links to substance use patterns and engagement in HIV treatment remains poorly characterized. We sought to evaluate the prevalence and correlates of pain among a cohort of PLWH who use unregulated drugs. Between December 2011 and November 2018, 709 participants were recruited, and data were analyzed using generalized linear mixed-effects (GLMM). At baseline, 374 (53 percent) individuals reported moderate-to-extreme pain in the previous 6 months. In a multivariable model, pain was significantly associated with nonmedical prescription-opioid use (adjusted odds ratio (AOR) = 1.63, 95 percent confidence interval (CI): 1.30-2.05), nonfatal overdose (AOR = 1.46, 95 percent CI: 1.11-1.93), self-managing pain (AOR = 2.25, 95 percent CI: 1.94-2.61), requesting pain medication in the previous 6 months (AOR = 2.01, 95 percent CI: 1.69-2.38), and ever being diagnosed with a mental illness (AOR = 1.47, 95 percent CI: 1.11-1.94). Establishing accessible pain management interventions that address the complex intersection of pain, drug use, and HIV-infection has potential to improve quality of life outcomes among this population.
- 19 April 2023
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 19 (3) , 225-237
Estimating the prevalence and correlates of pain among people living with HIV who use unregulated drugs in a Canadian setting
Although prevalent among people living with human immunodeficiency virus (HIV) (PLWH) and people who use unregulated drugs (PWUD), pain and its possible links to substance use patterns and engagement in HIV treatment remains poorly characterized. We sought to evaluate the prevalence and correlates of pain among a cohort of PLWH who use unregulated drugs. Between December 2011 and November 2018, 709 participants were recruited, and data were analyzed using generalized linear mixed-effects (GLMM). At baseline, 374 (53 percent) individuals reported moderate-to-extreme pain in the previous 6 months. In a multivariable model, pain was significantly associated with nonmedical prescription-opioid use (adjusted odds ratio (AOR) = 1.63, 95 percent confidence interval (CI): 1.30-2.05), nonfatal overdose (AOR = 1.46, 95 percent CI: 1.11-1.93), self-managing pain (AOR = 2.25, 95 percent CI: 1.94-2.61), requesting pain medication in the previous 6 months (AOR = 2.01, 95 percent CI: 1.69-2.38), and ever being diagnosed with a mental illness (AOR = 1.47, 95 percent CI: 1.11-1.94). Establishing accessible pain management interventions that address the complex intersection of pain, drug use, and HIV-infection has potential to improve quality of life outcomes among this population.